Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 285Head and Neck Neoplasms 250Carcinoma, Non-Small-Cell Lung 95Thyroid Neoplasms 92Melanoma 68Mouth Neoplasms 67Nasopharyngeal Carcinoma 64Oropharyngeal Neoplasms 63Breast Neoplasms 54Colorectal Neoplasms 49Lung Neoplasms 47Ovarian Neoplasms 45Neoplasm Metastasis 45Neoplasms 41Uterine Cervical Neoplasms 39Carcinoma, Squamous Cell 39Carcinoma, Renal Cell 34Triple Negative Breast Neoplasms 31Stomach Neoplasms 31Laryngeal Neoplasms 31Endometrial Neoplasms 29Carcinoma 29Sarcoma 28Esophageal Neoplasms 28Pancreatic Neoplasms 27Salivary Gland Neoplasms 26Prostatic Neoplasms 25Thyroid Cancer, Papillary 23Urinary Bladder Neoplasms 22Hypopharyngeal Neoplasms 22

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphangioleiomyomatosis × Head & Neck × 90 days × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡